CareTrust REIT, Inc. logo

CareTrust REIT, Inc.

CTRE

NYSEReal EstateREIT - Healthcare Facilities

Regular session

$39.69

+$0.11 · +0.28%

Aug 24, 1:41 PM ETData delayed

CTRE company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

54

Fair Value

Momentum

50

Neutral

Sentiment

65

Bullish

Risk resilience

77

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
David Sedgwick
Listed since
May 29, 2014
Employees
43

Market position

Day range

Current $39.69

52-week range

Current $39.69

Open
$39.61
Previous close
$39.58
Volume
602.51K
0.23× average
Average volume
2.59M
Average daily volume
Market cap
9.38B USD
Beta
0.8
Market reference 1
50-day average
$40.3372
-1.60% below average
200-day average
$38.8162
+2.25% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
8.06B USD
P/E (TTM)
24.65×
P/B (TTM)
2.07×
P/S (TTM)
17.25×
EV / EBITDA
17.44×
Earnings yield
4.35%
Free cash flow yield
5.15%
Dividend yield
3.65%

Profitability & efficiency

Gross margin
77.98%
Operating margin
69.70%
Net margin
65.40%
Return on equity
7.94%
Return on assets
6.23%
Return on invested capital
6.36%

Financial health

Debt / equity
0.27×
Current ratio
1.54×
Altman Z-score
4.19
Piotroski F-score
7 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends108%67%27%-14%Gross margin, FY2021: 98.12%Gross margin, FY2022: 95.00%Gross margin, FY2023: 95.17%Gross margin, FY2024: 94.06%Gross margin, FY2025: 59.13%Operating margin, FY2021: 54.89%Operating margin, FY2022: 55.36%Operating margin, FY2023: 58.41%Operating margin, FY2024: 54.35%Operating margin, FY2025: 67.17%Net margin, FY2021: 37.85%Net margin, FY2022: -4.00%Net margin, FY2023: 27.06%Net margin, FY2024: 54.80%Net margin, FY2025: 67.26%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 98.12%. Gross margin FY2022 95.00%. Gross margin FY2023 95.17%. Gross margin FY2024 94.06%. Gross margin FY2025 59.13%. Operating margin FY2021 54.89%. Operating margin FY2022 55.36%. Operating margin FY2023 58.41%. Operating margin FY2024 54.35%. Operating margin FY2025 67.17%. Net margin FY2021 37.85%. Net margin FY2022 -4.00%. Net margin FY2023 27.06%. Net margin FY2024 54.80%. Net margin FY2025 67.26%.

Income trends

Revenue

476.59M USD+108.79%

Operating income

320.14M USD+158.06%

Net income

320.54M USD+156.27%
Income trends across reported periods525M USD331.36M USD137.72M USD−55.92M USDRevenue, FY2021: 190.2M USDRevenue, FY2022: 187.51M USDRevenue, FY2023: 198.6M USDRevenue, FY2024: 228.26M USDRevenue, FY2025: 476.59M USDOperating income, FY2021: 104.41M USDOperating income, FY2022: 103.81M USDOperating income, FY2023: 116M USDOperating income, FY2024: 124.06M USDOperating income, FY2025: 320.14M USDNet income, FY2021: 71.98M USDNet income, FY2022: −7.51M USDNet income, FY2023: 53.74M USDNet income, FY2024: 125.08M USDNet income, FY2025: 320.54M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 190.2M USD. Revenue FY2022 187.51M USD. Revenue FY2023 198.6M USD. Revenue FY2024 228.26M USD. Revenue FY2025 476.59M USD. Operating income FY2021 104.41M USD. Operating income FY2022 103.81M USD. Operating income FY2023 116M USD. Operating income FY2024 124.06M USD. Operating income FY2025 320.14M USD. Net income FY2021 71.98M USD. Net income FY2022 −7.51M USD. Net income FY2023 53.74M USD. Net income FY2024 125.08M USD. Net income FY2025 320.54M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue476.59M USD228.26M USD198.6M USD187.51M USD190.2M USD
Cost of goods sold194.8M USD13.55M USD9.59M USD9.37M USD3.57M USD
Gross profit281.79M USD214.71M USD189.01M USD178.13M USD186.62M USD
Selling, general, and administrative138K USD27.9M USD20.9M USD19.27M USD26.87M USD
Operating expenses−38.35M USD90.65M USD73M USD74.33M USD82.21M USD
Interest income11.49M USD68.03M USD19.17M USD8.63M USD2.16M USD
Interest expense43.71M USD30.31M USD40.88M USD30.01M USD23.68M USD
Depreciation and amortization93.08M USD56.83M USD51.2M USD50.38M USD55.39M USD
Operating income320.14M USD124.06M USD116M USD103.81M USD104.41M USD
Net income320.54M USD125.08M USD53.74M USD−7.51M USD71.98M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
18%
2 beats, 9 misses, 0 met estimates
Average EPS surprise
-11.94%
11 comparable reports
Latest EPS result
0.38
Estimate 0.38 · Miss by 1.04%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.510.420.340.25Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 0.29, estimate 0.31, surprise -6.45%, Miss. Q2 2025, reported May 1, 2025: actual 0.35, estimate 0.39, surprise -10.26%, Miss. Q3 2025, reported Aug 6, 2025: actual 0.36, estimate 0.39, surprise -7.69%, Miss. Q4 2025, reported Nov 5, 2025: actual 0.35, estimate 0.383, surprise -8.50%, Miss. Q1 2026, reported Feb 12, 2026: actual 0.47, estimate 0.39, surprise +20.51%, Beat. Q2 2026, reported May 7, 2026: actual 0.36, estimate 0.354, surprise +1.84%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.38, estimate 0.384, surprise -1.04%, Miss. Q4 2026, reported Nov 4, 2026: actual —, estimate 0.4, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates134.88M108.25M81.62M54.99MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 62.2M USD, estimate 60.5M USD, surprise +2.81%, Beat. Q2 2025, reported May 1, 2025: actual 71.65M USD, estimate 69.2M USD, surprise +3.54%, Beat. Q3 2025, reported Aug 6, 2025: actual 86.03M USD, estimate 80.39M USD, surprise +7.01%, Beat. Q4 2025, reported Nov 5, 2025: actual 104.27M USD, estimate 97.53M USD, surprise +6.91%, Beat. Q1 2026, reported Feb 12, 2026: actual 106.25M USD, estimate 110.67M USD, surprise -3.99%, Miss. Q2 2026, reported May 7, 2026: actual 114.2M USD, estimate 112.85M USD, surprise +1.19%, Beat. Q3 2026, reported Aug 6, 2026: actual 118.21M USD, estimate 122.22M USD, surprise -3.28%, Miss. Q4 2026, reported Nov 4, 2026: actual —, estimate 129.37M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$44.50

12.12% upside
Past 12 months12-month forecastHigh $47.00Average $44.50Low $43.00

Rating distribution

19 ratings
Strong buy15%
Buy1263%
Hold526%
Sell15%
Strong sell00%

Recent analyst actions

9 institutions
JefferiesmaintainBuy

CTRE news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.34

2025 complete year+26.4% since 2021

2026 partial: $0.78

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jun 30, 2026

$0.39

Quarterly

Record Jun 30, 2026 · Payment Jul 15, 2026

Dividend

Ex-dividend Mar 31, 2026

$0.39

Quarterly

Record Mar 31, 2026 · Payment Apr 15, 2026

Dividend

Ex-dividend Dec 31, 2025

$0.335

Quarterly

Record Dec 31, 2025 · Payment Jan 15, 2026

Dividend

Ex-dividend Sep 30, 2025

$0.335

Quarterly

Record Sep 30, 2025 · Payment Oct 15, 2025

Dividend

Ex-dividend Jun 30, 2025

$0.335

Quarterly

Record Jun 30, 2025 · Payment Jul 15, 2025

Dividend

Ex-dividend Mar 31, 2025

$0.335

Quarterly

Record Mar 31, 2025 · Payment Apr 15, 2025

CTRE peers

ETFs holding CTRE

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research CTRE

research.disclaimer